Panel Discussion: Assessing Targeted Protein Degradation’s Ability to be Both Selective & Safe

Time: 9:45 am
day: Conference Day One

Details:

  • How much progress has been made in identifying and utilising tissue-sparing E3 ligases? Are there more ligases to find? How do we effectively identify them?
  • What does existing off-target safety data tell us about degraders’ behaviour in clinic?
  • Are Molecular Glues a ‘safer’ option? Are there other ‘TACs’ that have potential to be safer due to their MOA?

Speakers: